Ex-smokers achieved non-smokers? level of arterial stiffness after a decade of smoking cessation, in a cross-sectional study reported in Hypertension: Journal of the American Heart Association.
A new study by researchers at the University of Virginia Health System may change the way physicians assess a patient?s risk of having a stroke.
A hormone that is important in the control of blood pressure also shrinks lung cancer tumors in mice, suggesting a new way to prevent or treat the deadly cancer, according to scientists at Wake Forest University School of Medicine.
Doctors at the University of Maryland Medical Center had a mystery on their hands. A 51-year-old physician colleague who looked the picture of health?no cardiovascular risks, a marathon runner who had exercised vigorously each day for 30 years?had just flunked a calcium screening scan of his heart.
Chances of surviving a cardiac arrest outside a hospital setting are twice as high if bystanders perform chest-compression-only resuscitation instead of traditional cardiopulmonary resuscitation (CPR) with mouth-to-mouth breathing.
A lack of funds to pay for medical treatment and prescriptions is common among heart attack patients and leads to a worse recovery, more angina, poorer quality of life and higher risk of re-hospitalization, according to a study by researchers at Yale School of Medicine.
About one in five heart attack patients report having financial barriers to health care services, and these patients are more likely to have a lower quality of life and increased rate of rehospitalization, according to a study in the March 14 issue of JAMA, a theme issue on access to care.
An analysis of state Emergency Medicaid spending contradicts assumptions about emergency care provided to recent immigrants, researchers from the University of North Carolina at Chapel Hill and the Carolinas Center for Medical Excellence have found.
Obese patients have a significantly higher risk of complications following surgery, including heart attack, wound infection, nerve injury and urinary tract infection, according to a new study from researchers at the University of Michigan Health System.
Schering-Plough Corporation announced today that results of the Phase II trial of its novel oral thrombin receptor antagonist (TRA) SCH 530348 will be presented at the 2007 annual Scientific Sessions of the American College of Cardiology (ACC.07)/Innovation in Intervention (i2) Summit, March 24-27 in New Orleans.